(Q42547059)

2 November 2017

title

Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy (English)

1 reference

2 November 2017

1 reference

1 reference

1 reference

T. Berger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9337680

20 November 2024

R. Malayeri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9337680

20 November 2024

A. Doppelbauer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9337680

20 November 2024

G. Krajnik

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9337680

20 November 2024

H. Huber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9337680

20 November 2024

E. Auff

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9337680

20 November 2024

R. Pirker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9337680

20 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9337680

20 November 2024

publication date

1 August 1997

1 reference

2 November 2017

August 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9337680

full work available at URL

20 November 2024

https://api.elsevier.com/content/article/PII:S0959804997001032?httpAccept=text/xml

1 reference

10.1016/S0959-8049(97)00103-2

DOI

https://api.crossref.org/works/10.1016/S0959-8049(97)00103-2

https://api.elsevier.com/content/article/PII:S0959804997001032?httpAccept=text/plain

20 November 2024

1 reference

10.1016/S0959-8049(97)00103-2

DOI

https://api.crossref.org/works/10.1016/S0959-8049(97)00103-2

European Journal of Cancer

20 November 2024

published in

1 reference

2 November 2017

volume

33

1 reference

2 November 2017

issue

9

1 reference

2 November 2017

page(s)

1393-1399

1 reference

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Taxol: a novel investigational antimicrotubule agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

1 reference

7 January 2021

Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Paclitaxel (Taxol) induces cumulative mild neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Taxol produces a predominantly sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Peripheral sensory neuropathy and cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Peripheral neurotoxicity of taxol in patients previously treated with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Nerve Growth Factor Attenuates Neurotoxic Effects of Taxol on Spinal Cord-Ganglion Explants from Fetal Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Nerve growth factor prevents experimental cisplatin neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Protection by an ACTH4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Growth factors: potential therapeutic applications in neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Vinorelbine after paclitaxel in breast cancer: cross resistance and cumulative neurotoxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Severe neurotoxicity from vinorelbine-paclitaxel combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

10.1016/S0959-8049(97)00103-2

Identifiers

DOI

1 reference

2 November 2017

1 reference